Glycosylated fibronectin as a first trimester marker for gestational diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycosylated fibronectin as a first trimester marker for gestational diabetes
Authors
Keywords
-
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-11
DOI
10.1007/s00404-020-05670-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus
- (2018) Arianne N. Sweeting et al. FETAL DIAGNOSIS AND THERAPY
- Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
- (2016) Stamatina Iliodromiti et al. DIABETOLOGIA
- Components of metabolic syndrome in the first trimester of pregnancy as predictors of adverse perinatal outcome
- (2016) Michał Migda et al. Ginekologia Polska
- First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation
- (2016) Argyro Syngelaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial
- (2016) E A Huhn et al. BMJ Open
- Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia
- (2015) Juha Rasanen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Gestational Diabetes Mellitus Is Associated With Changes in the Concentration and Bioactivity of Placenta-Derived Exosomes in Maternal Circulation Across Gestation
- (2015) Carlos Salomon et al. DIABETES
- First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus
- (2015) Argyro Syngelaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Prevention of gestational diabetes through lifestyle intervention: study design and methods of a Finnish randomized controlled multicenter trial (RADIEL)
- (2014) Kristiina Rönö et al. BMC Pregnancy and Childbirth
- No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study
- (2014) Maria Lindqvist et al. BMC Pregnancy and Childbirth
- Glycosylated Fibronectin as a First-Trimester Biomarker for Prediction of Gestational Diabetes
- (2013) Juha P. Rasanen et al. OBSTETRICS AND GYNECOLOGY
- Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
- (2011) B. S. Buckley et al. DIABETIC MEDICINE
- Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
- (2009) A. Kotronen et al. DIABETOLOGIA
- Future risk of diabetes in mother and child after gestational diabetes mellitus
- (2009) Peter Damm INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
- (2009) Leanne Bellamy et al. LANCET
- Gestational Diabetes — Whom Do We Treat?
- (2009) David A. Sacks NEW ENGLAND JOURNAL OF MEDICINE
- A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
- (2009) Mark B. Landon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperglycemia and Adverse Pregnancy Outcomes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started